Clinical use of synthetic antifibrinolytic agents during liver transplantation.
Kang
Y
Y
Division of Hepatic Transplantation Anesthesiology, Presbyterian University Hospital, Pittsburgh, Pennsylvania 15213.
D015119:Aminocaproic Acid / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000209:etiology; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000502:physiology; D013916:Thrombelastography; D014148:Tranexamic Acid / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D015119:Aminocaproic Acid